5
Speciality Medicines
544738 BSE
Speciality Medicines
Healthcare BSE: 544738 Pharmaceuticals & Biotechnology
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
2- Company is almost debt free.
- Company has a good return on equity (ROE) track record: 3 Years ROE 27.5%
Weaknesses
2- Though the company is reporting repeated profits, it is not paying out dividend
- Tax rate seems low
Growth Rate
Revenue Growth
29% lower than
3Y
Net Income Growth
81% lower than
3Y
Quarterly Results
| Particulars | Mar 2025 | Mar 2026 |
|---|---|---|
| Sales | 31 | 45 |
| Expenses | 26 | 36 |
| Operating Profit | 4 | 8 |
| OPM % | 14% | 19% |
| Other Income | 0 | 1 |
| Interest | 0 | 1 |
| Depreciation | 0 | 0 |
| PBT | 4 | 8 |
| Tax % | 36% | -1% |
| Net Profit | 3 | 8 |
| EPS in Rs | 4.16 | 9.31 |
Profit & Loss
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Sales | 40 | 23 | 28 | 58 | 75 |
| Expenses | 38 | 20 | 22 | 49 | 62 |
| Operating Profit | 2 | 4 | 5 | 9 | 14 |
| OPM % | 6% | 15% | 19% | 16% | 18% |
| Other Income | 0 | 0 | 0 | 0 | 1 |
| Interest | 0 | 0 | 1 | 1 | 1 |
| Depreciation | 0 | 0 | 0 | 0 | 0 |
| PBT | 2 | 3 | 5 | 9 | 13 |
| Tax % | 31% | 43% | 36% | 17% | 0% |
| Net Profit | 1 | 2 | 3 | 7 | 13 |
| EPS in Rs | 70.48 | 4.42 | 5.73 | 11.19 | 14.83 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% |
Balance Sheet
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Equity Capital | 0.21 | 4 | 5 | 6 | 9 |
| Reserves | 2 | 2 | 10 | 24 | 62 |
| Borrowings | 1 | 4 | 3 | 5 | 7 |
| Other Liabilities | 3 | 4 | 5 | 4 | 17 |
| Total Liabilities | 6 | 13 | 23 | 40 | 95 |
| Fixed Assets | 2 | 2 | 1 | 2 | 2 |
| CWIP | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 4 | 11 | 21 | 38 | 93 |
| Total Assets | 6 | 13 | 23 | 40 | 95 |
Cash Flow
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Operating | 1 | -4 | -5 | -6 | -1 |
| Investing | -2 | 0 | 0 | -1 | -3 |
| Financing | 2 | 4 | 5 | 8 | 28 |
| Net Cash Flow | 0 | 0 | 0 | 1 | 24 |
| Free Cash Flow | -1 | -4 | -5 | -7 | -1 |
| CFO/OP | 36 | -101 | -66 | -54 | -9 |
Ratios
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Debtor Days | 23 | 87 | 142 | 60 | 128 |
| Inventory Days | 5 | 103 | 161 | 150 | 191 |
| Days Payable | 12 | 40 | 48 | 8 | 80 |
| Cash Conversion Cycle | 16 | 149 | 255 | 202 | 239 |
| Working Capital Days | -3 | 76 | 185 | 181 | 221 |
| ROCE % | — | 52% | 38% | 34% | 25% |
Documents
1
Announcement under Regulation 30 (LODR)-Newspaper Publication
5 Sep - We hereby submit Newspaper publication of Notice of 5th Annual general meeting of the company. 5 Sep - We hereby submit Newspaper publication of Notice of 5th Annual general meeting of the company.
2
Board Meeting Outcome for Outcome Of Board Meeting Held On September 03, 2026
3 Sep - Board approved FY26 report, called AGM on 28 Sep 2026, and appointed voting agency and scrutinizer. 3 Sep - Board approved FY26 report, called AGM on 28 Sep 2026, and appointed voting agency and scrutinizer.
5
Intimation Under Regulation 30 Of The SEBI (LODR) Regulations, 2015 Regarding Approval For Two New Products In Ethiopia
12 Aug - Received Ethiopia approval for Olanzapine 5 mg and Diazepam 5 mg; portfolio rises to 12 formulations. 12 Aug - Received Ethiopia approval for Olanzapine 5 mg and Diazepam 5 mg; portfolio rises to 12 formulations.
Frequently Asked Questions about Speciality Medicines
What does Speciality Medicines Ltd do?
Incorporated in 2021, Speciality Medicines Limited is engaged in the marketing and distribution of finished formulations of speciality pharmaceuticals.[1]
Where is Speciality Medicines Ltd (544738) listed?
Speciality Medicines Ltd trades under code 544738 on the BSE.
Which sector does Speciality Medicines Ltd belong to?
Speciality Medicines Ltd is classified under the Healthcare sector, in the Pharmaceuticals & Biotechnology industry.
Company Information
Incorporated in 2021, Speciality Medicines Limited is engaged in the marketing and distribution of finished formulations of speciality pharmaceuticals.[1]
Website specialitymedicine.com
Face Value ₹ 10
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/544738.md for Speciality Medicines Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.